City
Epaper

This therapy may swiftly reduce depression, suicidal thoughts

By IANS | Updated: December 26, 2021 17:27 IST

London, Dec 26 Ketamine therapy has a swift short-term effect on reducing symptoms of depression and suicidal thoughts, ...

Open in App

London, Dec 26 Ketamine therapy has a swift short-term effect on reducing symptoms of depression and suicidal thoughts, new research has found.

The findings indicated that the strongest evidence emerged around the use of ketamine to treat both major depression and bipolar depression, with symptoms reducing as swiftly as one to four hours after a single treatment.

The effect lasted up to two weeks.

"Our findings suggest that ketamine may be useful in providing rapid relief from depression and suicidal thoughts, creating a window of opportunity for further therapeutic interventions to be effective," said lead author Merve Mollaahmetoglu from the UK's University of Exeter.

"It is important to note that this review examined ketamine administration in carefully controlled clinical settings where any risks of ketamine can be safely managed," Mollaahmetoglu added.

As per the research, published in the British Journal of Psychiatry Open, similarly, single or multiple doses of ketamine resulted in moderate to large reductions in suicidal thoughts.

This improvement was seen as early as four hours following ketamine treatment and lasted on average three days, and up to a week, the research said.

For other psychiatric disorders, including anxiety disorders, post-traumatic stress disorders and obsessive-compulsive disorders, there is early evidence to suggest the potential benefit of ketamine treatment, it added.

Moreover, for individuals with substance use disorders, ketamine treatment led to short-term reductions in craving, consumption and withdrawal symptoms.

For the study, the team included 33 systematic reviews, 29 randomised control trials, and 21 observational studies.

"We're finding that ketamine may have promising benefits for conditions that are notoriously hard to treat in the clinic. We now need bigger and better-designed trials to test these benefits," said co-author Celia Morgan from the varsity.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: LondonukUniversity Of ExeterMerve mollaahmetogluCelia morgan
Open in App

Related Stories

CricketChris Woakes Walks Out to Bat with Sling On as England Lose Ninth Wicket on Day 5 of ENG vs IND 5th Test (Watch Video)

CricketENG vs IND 5th Test Weather Forecast: Will Rain Play Spoilsport on Day 5 of England vs India at Oval in London?

CricketENG vs IND 5th Test Weather Forecast: Will Rain Play Spoilsport on Day 3 of England vs India at Oval in London? (VIDEO)

CricketENG vs IND 5th Test Weather Forecast: Will Rain Play Spoilsport on Day 2 of England vs India at Oval in London?

EntertainmentRakul Preet Singh Jets Off to London for Final Schedule of De De Pyaar De 2

Health Realted Stories

HealthGujarat: Pharma & Labtech Expo 2025 kicks off in Gandhinagar

HealthOver 26 lakh individuals initiated on TB preventive treatment in 2024: Anupriya Patel

HealthRejection rate of India’s goods exports fell by over 12 per cent in June: Minister

HealthStates adequately funded for vaccinating bovines against livestock diseases: Govt

HealthHow diabetes worsens TB, causes treatment failure and death